Aurinia Pharmaceuticals Inc (AUPH) NPV

Sell:$14.53Buy:$14.54Price increased$0.33 (2.32%)

Prices delayed by at least 15 minutes
Sell:$14.53
Buy:$14.54
Change:Price increased$0.33 (2.32%)
Deal now
Prices delayed by at least 15 minutes
Sell:$14.53
Buy:$14.54
Change:Price increased$0.33 (2.32%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$14.53
Previous close$14.21
Market cap$1.89bn
P/E ratio6.84
Volume442,613
Dividend yield0.00%
EMS-

Company information

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. It has developed LUPKYNIS ...

  • LocationCanada
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue132.97m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Lightweight Charts™ provided by https://www.tradingview.com/.